News May 10, 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon Apr 23, 2024 10:15–12:10 Zürich 스위스
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan Apr 23, 2024 10:15–12:10 Zürich 스위스
Evento S-GE Fattori chiave di successo per fare affari in Giappone Apr 23, 2024 10:15–12:10 Zürich 스위스
News Jan 26, 2022 Basel Area – exactly the right chemistry for South Korean pharma companies KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the Europe...
News Oct 18, 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Fact Sheet Apr 05, 2023 Health functional food in demand in South Korea The market for “health functional foods”, which is an official term to refer to health and dietary supplements approved by the Ministry of Food &...